Planet 13 Holdings (PLNH) Acquisitions (2022 - 2023)
Planet 13 Holdings (PLNH) posted quarterly Acquisitions of -$866250.0 for Q4 2023, down 5757.79% year-over-year from $15310.7 in Q4 2022, and down 200.0% quarter-over-quarter from $866250.0 in Q1 2023.
Planet 13 Holdings (PLNH) Acquisitions (2022 - 2023) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Acquisitions for 2 consecutive years, with -$866250.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Acquisitions fell 5757.79% year-over-year to -$866250.0; the TTM figure through Sep 2024 stood at -$866250.0 (down 201.74% YoY), while the FY2022 annual figure was $1.5 million, changed N/A from the prior year.
- Acquisitions retreated to -$866250.0 in Q4 2023 per PLNH's latest filing, from $866250.0 in the prior quarter.
- Across five years, Acquisitions topped out at $1.5 million in Q1 2022 and bottomed at -$866250.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -866,250.00 |
| Mar 31, 2023 | 866,250.00 |
| Dec 31, 2022 | -14,788.00 |
| Sep 30, 2022 | 15,224.00 |
| Mar 31, 2022 | 1.48 Mn |